You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (12) |
Back to Search
Possible pediatric nephrotoxicity of cisplatin
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-HPS-001
- By: ABDELRAHMAN, Sarah (Children's Cancer Hospital Egypt, Department of Pharmaceutical Services & Sciences)
- Co-author(s): Sarah Mohamed Abdelrahman
Sarah Salah
Mahmoud Hamza
Hala Zaki: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
Alaa Al Haddad: Department of Pediatric Oncology & Stem Cell Transplant, Children's Cancer Hospital , Cairo, Egypt
Helmy Moawad: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt - Abstract:
Background
Risk of Cisplatin (CDDP) nephrotoxicity, increases with increased cumulative dose, bolus dosage and associated nephrotoxic drugs. Early detection & management improves patient care.Methods
51 patients scheduled to receive CDDP-based chemotherapy were recruited and scored for nephrotoxic events throughout chemotherapy course, then.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026